JP2008538501A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008538501A5 JP2008538501A5 JP2008507584A JP2008507584A JP2008538501A5 JP 2008538501 A5 JP2008538501 A5 JP 2008538501A5 JP 2008507584 A JP2008507584 A JP 2008507584A JP 2008507584 A JP2008507584 A JP 2008507584A JP 2008538501 A5 JP2008538501 A5 JP 2008538501A5
- Authority
- JP
- Japan
- Prior art keywords
- vesiculin
- conservative variant
- ala
- ser
- gly
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108010008690 vesiculin Proteins 0.000 claims 41
- 210000004027 cell Anatomy 0.000 claims 9
- 229920001184 polypeptide Polymers 0.000 claims 6
- 102000004196 processed proteins & peptides Human genes 0.000 claims 6
- 108090000765 processed proteins & peptides Proteins 0.000 claims 6
- 102000040430 polynucleotide Human genes 0.000 claims 5
- 108091033319 polynucleotide Proteins 0.000 claims 5
- 239000002157 polynucleotide Substances 0.000 claims 5
- 125000003275 alpha amino acid group Chemical group 0.000 claims 4
- 230000015572 biosynthetic process Effects 0.000 claims 3
- 239000013598 vector Substances 0.000 claims 3
- 241001519451 Abramis brama Species 0.000 claims 2
- 241000972773 Aulopiformes Species 0.000 claims 2
- 241000283690 Bos taurus Species 0.000 claims 2
- 241000251730 Chondrichthyes Species 0.000 claims 2
- 241000287828 Gallus gallus Species 0.000 claims 2
- 241001494479 Pecora Species 0.000 claims 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims 2
- 230000001580 bacterial effect Effects 0.000 claims 2
- 239000013604 expression vector Substances 0.000 claims 2
- 210000004962 mammalian cell Anatomy 0.000 claims 2
- 239000012071 phase Substances 0.000 claims 2
- 235000019515 salmon Nutrition 0.000 claims 2
- 239000007790 solid phase Substances 0.000 claims 2
- 239000006104 solid solution Substances 0.000 claims 2
- 238000003786 synthesis reaction Methods 0.000 claims 2
- 230000002194 synthesizing effect Effects 0.000 claims 2
- 241000588724 Escherichia coli Species 0.000 claims 1
- 241000289581 Macropus sp. Species 0.000 claims 1
- 210000004978 chinese hamster ovary cell Anatomy 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67353705P | 2005-04-20 | 2005-04-20 | |
| PCT/NZ2006/000078 WO2006112737A1 (en) | 2005-04-20 | 2006-04-20 | Vesiculins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008538501A JP2008538501A (ja) | 2008-10-30 |
| JP2008538501A5 true JP2008538501A5 (enExample) | 2009-06-04 |
Family
ID=37115377
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008507584A Pending JP2008538501A (ja) | 2005-04-20 | 2006-04-20 | ベシキュリン |
Country Status (4)
| Country | Link |
|---|---|
| US (3) | US20090054320A1 (enExample) |
| EP (1) | EP1871796A4 (enExample) |
| JP (1) | JP2008538501A (enExample) |
| WO (1) | WO2006112737A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008086813A2 (en) * | 2007-01-19 | 2008-07-24 | Kobenhavns Universitet | Peptides derived from proteins of the insulin super-family |
| EP3381466B1 (en) * | 2009-11-05 | 2024-05-29 | Quest Diagnostics Investments Incorporated | Quantitation of insulin-like growth factor-i and insulin-like growth factor-ii with high-resolution mass spectrometry |
| WO2013128391A1 (en) * | 2012-02-28 | 2013-09-06 | Auckland Uniservices Limited | Synthetic polypeptides and uses thereof |
| KR101512676B1 (ko) * | 2013-04-18 | 2015-04-17 | 한국식품연구원 | 도미 추출물을 유효성분으로 포함하는 비만, 지방간 또는 대사성 증후군 개선용 약학 조성물 또는 건강기능식품 |
| US12178853B2 (en) | 2020-10-13 | 2024-12-31 | Betavive Ltd. | Method and compounds for treating diabetes and associated metabolic diseases |
| CN113186302B (zh) * | 2021-06-04 | 2022-02-01 | 华中农业大学 | 鲌鲂杂交种先锋2号的性别特异分子标记及应用 |
| JP2024537329A (ja) | 2021-10-12 | 2024-10-10 | ベータヴァイヴ・リミテッド | 糖尿病及び関連する代謝性疾患を処置するためのペプチド及び断片 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3773919A (en) * | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| IE52535B1 (en) * | 1981-02-16 | 1987-12-09 | Ici Plc | Continuous release pharmaceutical compositions |
| US4816567A (en) * | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| IE61148B1 (en) | 1988-03-10 | 1994-10-05 | Ici Plc | Method of detecting nucleotide sequences |
| US5652214A (en) * | 1989-06-05 | 1997-07-29 | Cephalon, Inc. | Treating disorders by application of insulin-like growth factors and analogs |
| US6310040B1 (en) * | 1991-11-08 | 2001-10-30 | Cephalon, Inc. | Treating retinal neuronal disorders by the application of insulin-like growth factors and analogs |
| DE69432459T2 (de) | 1993-01-06 | 2003-11-27 | Kinerton Ltd., Blanchardstown | Ionische molekularkonjugate von bioabbaubaren polyestern und bioaktiven polypeptiden |
| JP2000191697A (ja) * | 1998-12-28 | 2000-07-11 | Suntory Ltd | インスリン様ペプチド |
| WO2000078805A1 (en) * | 1999-06-18 | 2000-12-28 | Protemix Corporation Limited | Peptide having preptin functionality |
| ATE555126T1 (de) * | 2004-08-25 | 2012-05-15 | Janssen Pharmaceutica Nv | Relaxin-chimere polypeptide und deren herstellung und anwendung |
-
2006
- 2006-04-20 US US11/912,111 patent/US20090054320A1/en not_active Abandoned
- 2006-04-20 EP EP06733167A patent/EP1871796A4/en not_active Withdrawn
- 2006-04-20 JP JP2008507584A patent/JP2008538501A/ja active Pending
- 2006-04-20 WO PCT/NZ2006/000078 patent/WO2006112737A1/en not_active Ceased
-
2010
- 2010-08-02 US US12/848,835 patent/US8618051B2/en not_active Expired - Fee Related
-
2013
- 2013-11-20 US US14/084,957 patent/US20140088024A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100506844C (zh) | 新的肽 | |
| CN101395179B (zh) | 具有胰岛素样生长因子-i活性的肽及其用途 | |
| CN105324397A (zh) | 胰岛素-肠促胰岛素缀合物 | |
| US20250188115A1 (en) | Process for preparing a glucagon-like peptide | |
| JP2020500015A5 (enExample) | ||
| CN106164088B (zh) | 长效肾上腺髓质素衍生物 | |
| JP2007521807A5 (enExample) | ||
| CN101809029A (zh) | 具有延长目标肽的血浆半衰期作用的肽 | |
| JP2009523459A5 (enExample) | ||
| US10647742B2 (en) | Method for synthesizing etelcalcetide | |
| JP2009525052A5 (enExample) | ||
| JPH03505280A (ja) | 新規ナトリウム排出亢進性および血管拡張性ペプチドを生産するための組換え技術 | |
| JPH10502360A (ja) | ヒトインターロイキン４のアンタゴニストもしくは部分的アゴニストとして用いられる新規ｈＩＬ−４突然変異蛋白質 | |
| CA3148347A1 (en) | Methods of making incretin analogs | |
| JP2017513875A (ja) | 分枝状アミノ酸プローブを有するペプチド類似体 | |
| JPH0690780A (ja) | ヒト−レラキシン遺伝子 | |
| JP2020517260A5 (enExample) | ||
| CN113748125A (zh) | 胰高血糖素样肽-1(glp-1)受体激动剂及其类似物的制备方法 | |
| JP2009500298A5 (enExample) | ||
| CN103501801A (zh) | 甲状旁腺激素类似物、其组合物和用途 | |
| FR2677362A1 (fr) | Neuropeptides de la famille des tachykinines. | |
| JP2008538501A5 (enExample) | ||
| AU2003236080A1 (en) | A method for producing a modified peptide | |
| JP2020529845A (ja) | Ｗｎｔ組成物および無血清培養条件からの処理の方法 | |
| CN1030255C (zh) | 环形生长激素释放因子(grf)类似物的制备方法 |